Osteoporosis

Latest News

Vascular Calcification in COPD Affects Bone Mineral Density, Increases Fractures

By

Britt Gambino

Researchers evaluated the association between osteoporosis and vertebral fragility fractures with cardiovascular calcification in patients with chronic obstructive pulmonary disease.

Increased Risk for Atypical Femur Fracture With Longer Bisphosphonate Use in Women

By

Emily Pond

Researchers evaluated the association between risk for atypical fracture and duration of bisphosphonate use in women with osteoporosis.

Delayed Denosumab Injections Associated With Increased Vertebral Fracture Risk

By

Rose Reeb

Researchers estimated risk for fracture among patients receiving denosumab with delayed subsequent doses vs those who received doses on time.

Bisphosphonates May Not Improve Bone Marrow Lesion Volume

There is no clear benefit of bisphosphonates on bone marrow lesions.

Orthogeriatric Care Increases Osteoporosis Treatment in Older Patients With Hip Fracture

By

Morgan E. Meissner

In this systematic review, the study authors evaluated the current evidence on orthogeriatric care for older patients with hip fracture.

Serum Iron and Hepcidin Levels Associated With Osteoporosis in Patients With Rheumatoid Arthritis

By

Alyssa Capel

Researchers aimed to determine whether iron metabolism and serum hepcidin levels were linked to osteoporosis in patients with rheumatoid arthritis.

Denosumab Associated With Significant Increases in BMD in Glucocorticoid-Induced Osteoporosis

By

Morgan E. Meissner

Researchers evaluated the effect of denosumab on bone mineral density loss in patients with glucocorticoid-induced osteoporosis.

Fetal, Early-Life Exposures May Affect Young Adult Bone Health

Factors during gestation and infancy may impact bone health in young adulthood.

Patients With Neuromyelitis Optica at Increased Risk for Fracture

By

Amit Akirov, MD

Given the limited data is available on bone health of patients with NMOSD-AQP4, researchers aimed to investigate their risk for fracture and bone loss.

Evaluating the Effects of Follow-Up Therapy After Denosumab Discontinuation in Postmenopausal Osteoporosis

By

Emily Pond

Researchers evaluated the effects of follow-up therapy after denosumab discontinuation on bone resorption, bone mineral density, and clinical fracture risk.

Evaluating Bone Microarchitecture and Strength in Women With HIV

By

Amit Akirov, MD

Bone microarchitecture and strength are reduced in women living with HIV, and tenofovir treatment may contribute to bone deficits.